nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—OPRM1—autistic disorder	0.851	1	CbGaD
Naltrexone—OPRM1—telencephalic ventricle—autistic disorder	0.00992	0.174	CbGeAlD
Naltrexone—OPRD1—forebrain—autistic disorder	0.0038	0.0665	CbGeAlD
Naltrexone—OPRK1—forebrain—autistic disorder	0.00364	0.0637	CbGeAlD
Naltrexone—OPRD1—telencephalon—autistic disorder	0.00349	0.0611	CbGeAlD
Naltrexone—OPRM1—brainstem—autistic disorder	0.00268	0.047	CbGeAlD
Naltrexone—OPRM1—forebrain—autistic disorder	0.00259	0.0453	CbGeAlD
Naltrexone—OPRM1—telencephalon—autistic disorder	0.00238	0.0417	CbGeAlD
Naltrexone—UGT1A1—digestive system—autistic disorder	0.00231	0.0404	CbGeAlD
Naltrexone—OPRD1—head—autistic disorder	0.00218	0.0381	CbGeAlD
Naltrexone—OPRK1—head—autistic disorder	0.00209	0.0365	CbGeAlD
Naltrexone—OPRD1—nervous system—autistic disorder	0.00206	0.0361	CbGeAlD
Naltrexone—OPRD1—central nervous system—autistic disorder	0.00199	0.0347	CbGeAlD
Naltrexone—OPRK1—nervous system—autistic disorder	0.00198	0.0346	CbGeAlD
Naltrexone—OPRK1—central nervous system—autistic disorder	0.0019	0.0333	CbGeAlD
Naltrexone—OPRK1—cerebellum—autistic disorder	0.00186	0.0325	CbGeAlD
Naltrexone—OPRD1—brain—autistic disorder	0.00158	0.0276	CbGeAlD
Naltrexone—OPRK1—brain—autistic disorder	0.00151	0.0264	CbGeAlD
Naltrexone—OPRM1—head—autistic disorder	0.00148	0.026	CbGeAlD
Naltrexone—OPRM1—nervous system—autistic disorder	0.00141	0.0246	CbGeAlD
Naltrexone—OPRM1—central nervous system—autistic disorder	0.00135	0.0237	CbGeAlD
Naltrexone—Methylnaltrexone—OPRM1—autistic disorder	0.00131	0.143	CrCbGaD
Naltrexone—Butorphanol—OPRM1—autistic disorder	0.00131	0.143	CrCbGaD
Naltrexone—Nalbuphine—OPRM1—autistic disorder	0.00119	0.131	CrCbGaD
Naltrexone—OPRM1—brain—autistic disorder	0.00108	0.0188	CbGeAlD
Naltrexone—Oxymorphone—OPRM1—autistic disorder	0.000974	0.107	CrCbGaD
Naltrexone—Hydrocodone—OPRM1—autistic disorder	0.000851	0.0931	CrCbGaD
Naltrexone—Oxycodone—OPRM1—autistic disorder	0.000777	0.085	CrCbGaD
Naltrexone—ABCB1—forebrain—autistic disorder	0.000747	0.0131	CbGeAlD
Naltrexone—Buprenorphine—OPRM1—autistic disorder	0.000715	0.0783	CrCbGaD
Naltrexone—Naloxone—OPRM1—autistic disorder	0.00071	0.0777	CrCbGaD
Naltrexone—Hydromorphone—OPRM1—autistic disorder	0.000705	0.0772	CrCbGaD
Naltrexone—ABCB1—telencephalon—autistic disorder	0.000687	0.012	CbGeAlD
Naltrexone—Morphine—OPRM1—autistic disorder	0.0006	0.0656	CrCbGaD
Naltrexone—ABCB1—digestive system—autistic disorder	0.000524	0.00918	CbGeAlD
Naltrexone—ABCB1—head—autistic disorder	0.000428	0.00748	CbGeAlD
Naltrexone—ABCB1—nervous system—autistic disorder	0.000406	0.0071	CbGeAlD
Naltrexone—ABCB1—central nervous system—autistic disorder	0.000391	0.00683	CbGeAlD
Naltrexone—ABCB1—cerebellum—autistic disorder	0.000382	0.00668	CbGeAlD
Naltrexone—ABCB1—brain—autistic disorder	0.00031	0.00542	CbGeAlD
Naltrexone—UGT1A1—Metabolism—RORA—autistic disorder	4.91e-05	0.000597	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CALCA—autistic disorder	4.88e-05	0.000593	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADM—autistic disorder	4.84e-05	0.000589	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GABBR1—autistic disorder	4.84e-05	0.000589	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADRB2—autistic disorder	4.84e-05	0.000588	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AVPR1A—autistic disorder	4.81e-05	0.000584	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRLR—autistic disorder	4.78e-05	0.000581	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EIF4E—autistic disorder	4.76e-05	0.000578	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD1—autistic disorder	4.73e-05	0.000575	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDE4B—autistic disorder	4.72e-05	0.000574	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—AVP—autistic disorder	4.71e-05	0.000572	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC1A3—autistic disorder	4.7e-05	0.000571	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—AQP4—autistic disorder	4.7e-05	0.000571	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GRM5—autistic disorder	4.64e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VIP—autistic disorder	4.64e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GRM8—autistic disorder	4.62e-05	0.000561	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOB—autistic disorder	4.6e-05	0.000559	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD3—autistic disorder	4.58e-05	0.000557	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—OPRM1—autistic disorder	4.57e-05	0.000556	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—AVP—autistic disorder	4.55e-05	0.000553	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—POMC—autistic disorder	4.52e-05	0.000549	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TDO2—autistic disorder	4.51e-05	0.000548	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OXTR—autistic disorder	4.5e-05	0.000547	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL5—autistic disorder	4.49e-05	0.000545	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—WNT2—autistic disorder	4.47e-05	0.000543	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SCT—autistic disorder	4.45e-05	0.000541	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CALCA—autistic disorder	4.43e-05	0.000539	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PLA2G4A—autistic disorder	4.43e-05	0.000538	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GHR—autistic disorder	4.4e-05	0.000535	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADRB2—autistic disorder	4.4e-05	0.000534	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	4.34e-05	0.000528	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDE4A—autistic disorder	4.34e-05	0.000527	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—autistic disorder	4.31e-05	0.000524	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	4.29e-05	0.000522	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TPH2—autistic disorder	4.28e-05	0.00052	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GABBR1—autistic disorder	4.25e-05	0.000516	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADM—autistic disorder	4.25e-05	0.000516	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DHCR7—autistic disorder	4.24e-05	0.000515	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DPYD—autistic disorder	4.21e-05	0.000511	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—CP—autistic disorder	4.19e-05	0.000509	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GZMB—autistic disorder	4.18e-05	0.000508	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EIF4E—autistic disorder	4.17e-05	0.000507	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDE4B—autistic disorder	4.14e-05	0.000503	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—AVP—autistic disorder	4.13e-05	0.000502	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADRB2—autistic disorder	4.09e-05	0.000497	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AVPR1A—autistic disorder	4.06e-05	0.000494	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—OXT—autistic disorder	4.06e-05	0.000493	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR1B—autistic disorder	4.06e-05	0.000493	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—EXT1—autistic disorder	4.02e-05	0.000488	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC6A8—autistic disorder	4.02e-05	0.000488	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OPRM1—autistic disorder	4.01e-05	0.000487	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	3.98e-05	0.000483	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VIP—autistic disorder	3.92e-05	0.000477	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GRM5—autistic disorder	3.92e-05	0.000477	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—autistic disorder	3.92e-05	0.000476	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CACNA1C—autistic disorder	3.91e-05	0.000475	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PLA2G4A—autistic disorder	3.88e-05	0.000472	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—AVP—autistic disorder	3.84e-05	0.000467	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DAO—autistic disorder	3.83e-05	0.000466	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—OXTR—autistic disorder	3.8e-05	0.000462	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—autistic disorder	3.78e-05	0.00046	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—PRKCB—autistic disorder	3.78e-05	0.00046	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TSC1—autistic disorder	3.77e-05	0.000459	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD1—autistic disorder	3.77e-05	0.000459	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SCT—autistic disorder	3.76e-05	0.000457	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRB2—autistic disorder	3.71e-05	0.000451	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—UPB1—autistic disorder	3.68e-05	0.000447	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NTRK2—autistic disorder	3.67e-05	0.000446	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GZMB—autistic disorder	3.67e-05	0.000446	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD3—autistic disorder	3.65e-05	0.000444	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—PIK3CG—autistic disorder	3.62e-05	0.00044	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADM—autistic disorder	3.59e-05	0.000436	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GABBR1—autistic disorder	3.59e-05	0.000436	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL5—autistic disorder	3.58e-05	0.000435	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—TF—autistic disorder	3.56e-05	0.000433	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DHFR—autistic disorder	3.56e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OXT—autistic disorder	3.56e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR1B—autistic disorder	3.56e-05	0.000433	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CALCA—autistic disorder	3.53e-05	0.000429	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EIF4E—autistic disorder	3.53e-05	0.000429	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDE4B—autistic disorder	3.5e-05	0.000425	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—AVP—autistic disorder	3.49e-05	0.000424	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	3.47e-05	0.000422	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—autistic disorder	3.45e-05	0.000419	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—autistic disorder	3.44e-05	0.000418	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PRKCB—autistic disorder	3.44e-05	0.000417	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTM5—autistic disorder	3.42e-05	0.000415	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ASMT—autistic disorder	3.42e-05	0.000415	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—PRKCB—autistic disorder	3.32e-05	0.000403	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD1—autistic disorder	3.31e-05	0.000402	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TSC1—autistic disorder	3.31e-05	0.000402	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	3.3e-05	0.000401	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PIK3CG—autistic disorder	3.29e-05	0.0004	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PLA2G4A—autistic disorder	3.28e-05	0.000399	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NTRK2—autistic disorder	3.22e-05	0.000391	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC25A12—autistic disorder	3.21e-05	0.00039	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD3—autistic disorder	3.2e-05	0.000389	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—autistic disorder	3.2e-05	0.000389	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—PIK3CG—autistic disorder	3.17e-05	0.000386	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL5—autistic disorder	3.14e-05	0.000381	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—autistic disorder	3.13e-05	0.00038	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC19A1—autistic disorder	3.13e-05	0.00038	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PRL—autistic disorder	3.12e-05	0.000379	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GZMB—autistic disorder	3.1e-05	0.000377	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CALCA—autistic disorder	3.1e-05	0.000377	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—autistic disorder	3.02e-05	0.000367	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PRKCB—autistic disorder	3.01e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR1B—autistic disorder	3.01e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—OXT—autistic disorder	3.01e-05	0.000366	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRB2—autistic disorder	2.96e-05	0.00036	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—autistic disorder	2.9e-05	0.000353	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PIK3CG—autistic disorder	2.88e-05	0.00035	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	2.87e-05	0.000349	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PRKCB—autistic disorder	2.8e-05	0.000341	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TSC1—autistic disorder	2.8e-05	0.00034	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD1—autistic disorder	2.8e-05	0.00034	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYP19A1—autistic disorder	2.79e-05	0.000339	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADSL—autistic disorder	2.79e-05	0.000338	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—AVP—autistic disorder	2.78e-05	0.000338	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF2—autistic disorder	2.77e-05	0.000337	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—autistic disorder	2.74e-05	0.000333	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRL—autistic disorder	2.74e-05	0.000333	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—XDH—autistic disorder	2.73e-05	0.000332	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NTRK2—autistic disorder	2.72e-05	0.000331	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD3—autistic disorder	2.71e-05	0.000329	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PIK3CG—autistic disorder	2.68e-05	0.000326	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—STX1A—autistic disorder	2.68e-05	0.000326	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NPAS2—autistic disorder	2.68e-05	0.000326	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL5—autistic disorder	2.65e-05	0.000322	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CALCA—autistic disorder	2.62e-05	0.000318	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PLA2G4A—autistic disorder	2.62e-05	0.000318	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRB2—autistic disorder	2.6e-05	0.000316	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—COMT—autistic disorder	2.59e-05	0.000315	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TCN2—autistic disorder	2.59e-05	0.000315	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTP1—autistic disorder	2.58e-05	0.000313	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOA—autistic disorder	2.57e-05	0.000313	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—autistic disorder	2.55e-05	0.00031	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2—autistic disorder	2.55e-05	0.00031	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PRKCB—autistic disorder	2.55e-05	0.000309	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MEF2C—autistic disorder	2.54e-05	0.000309	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CAT—autistic disorder	2.51e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ITGB3—autistic disorder	2.48e-05	0.000301	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADA—autistic disorder	2.47e-05	0.0003	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	2.47e-05	0.0003	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AVP—autistic disorder	2.44e-05	0.000296	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PIK3CG—autistic disorder	2.44e-05	0.000296	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF2—autistic disorder	2.43e-05	0.000295	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTM1—autistic disorder	2.37e-05	0.000288	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PLA2G4A—autistic disorder	2.37e-05	0.000288	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	2.34e-05	0.000284	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—autistic disorder	2.32e-05	0.000282	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—autistic disorder	2.31e-05	0.000281	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2—autistic disorder	2.31e-05	0.000281	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRL—autistic disorder	2.31e-05	0.000281	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PLA2G4A—autistic disorder	2.29e-05	0.000279	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GPX1—autistic disorder	2.27e-05	0.000276	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—RORA—autistic disorder	2.25e-05	0.000274	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2—autistic disorder	2.23e-05	0.000271	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MEF2C—autistic disorder	2.23e-05	0.000271	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TSC2—autistic disorder	2.2e-05	0.000267	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB2—autistic disorder	2.19e-05	0.000267	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ITGB3—autistic disorder	2.17e-05	0.000264	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APOE—autistic disorder	2.15e-05	0.000262	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LEP—autistic disorder	2.15e-05	0.000262	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOB—autistic disorder	2.11e-05	0.000257	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MTHFR—autistic disorder	2.1e-05	0.000255	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AVP—autistic disorder	2.06e-05	0.000251	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF2—autistic disorder	2.05e-05	0.000249	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—autistic disorder	2.03e-05	0.000247	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PRKCB—autistic disorder	2.03e-05	0.000247	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2—autistic disorder	2.03e-05	0.000247	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TPH2—autistic disorder	1.96e-05	0.000238	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—APOE—autistic disorder	1.95e-05	0.000237	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PIK3CG—autistic disorder	1.94e-05	0.000236	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APC—autistic disorder	1.94e-05	0.000236	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.94e-05	0.000236	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DPYD—autistic disorder	1.93e-05	0.000235	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TSC2—autistic disorder	1.93e-05	0.000234	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EGF—autistic disorder	1.92e-05	0.000233	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2—autistic disorder	1.89e-05	0.000229	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APOE—autistic disorder	1.89e-05	0.000229	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LEP—autistic disorder	1.89e-05	0.000229	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MEF2C—autistic disorder	1.89e-05	0.000229	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—autistic disorder	1.85e-05	0.000225	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ITGB3—autistic disorder	1.84e-05	0.000223	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CACNA1C—autistic disorder	1.79e-05	0.000218	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCB—autistic disorder	1.78e-05	0.000216	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF1—autistic disorder	1.78e-05	0.000216	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—MAPK1—autistic disorder	1.77e-05	0.000215	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PIK3CG—autistic disorder	1.76e-05	0.000214	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—autistic disorder	1.72e-05	0.000208	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2—autistic disorder	1.71e-05	0.000208	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APC—autistic disorder	1.7e-05	0.000207	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PIK3CG—autistic disorder	1.7e-05	0.000207	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SERPINE1—autistic disorder	1.69e-05	0.000205	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EGF—autistic disorder	1.68e-05	0.000205	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—autistic disorder	1.68e-05	0.000204	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DHFR—autistic disorder	1.63e-05	0.000198	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TSC2—autistic disorder	1.63e-05	0.000198	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—autistic disorder	1.62e-05	0.000197	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOE—autistic disorder	1.59e-05	0.000194	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LEP—autistic disorder	1.59e-05	0.000194	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF1—autistic disorder	1.56e-05	0.000189	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—MAPK1—autistic disorder	1.55e-05	0.000189	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCB—autistic disorder	1.5e-05	0.000183	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SERPINE1—autistic disorder	1.48e-05	0.00018	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	1.44e-05	0.000175	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APC—autistic disorder	1.44e-05	0.000175	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EGF—autistic disorder	1.42e-05	0.000173	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HRAS—autistic disorder	1.42e-05	0.000173	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—autistic disorder	1.37e-05	0.000166	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2—autistic disorder	1.37e-05	0.000166	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—autistic disorder	1.36e-05	0.000165	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—autistic disorder	1.34e-05	0.000162	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF1—autistic disorder	1.32e-05	0.00016	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	1.31e-05	0.000159	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTEN—autistic disorder	1.29e-05	0.000156	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP19A1—autistic disorder	1.28e-05	0.000155	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	1.25e-05	0.000152	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HRAS—autistic disorder	1.25e-05	0.000151	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2—autistic disorder	1.2e-05	0.000146	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—autistic disorder	1.19e-05	0.000145	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—COMT—autistic disorder	1.19e-05	0.000144	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTP1—autistic disorder	1.18e-05	0.000144	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOA—autistic disorder	1.18e-05	0.000143	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTEN—autistic disorder	1.17e-05	0.000142	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAT—autistic disorder	1.15e-05	0.00014	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTEN—autistic disorder	1.13e-05	0.000137	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTM1—autistic disorder	1.09e-05	0.000132	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.09e-05	0.000132	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HRAS—autistic disorder	1.05e-05	0.000128	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAPK1—autistic disorder	1.05e-05	0.000127	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GPX1—autistic disorder	1.04e-05	0.000127	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2—autistic disorder	1.01e-05	0.000123	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—autistic disorder	1.01e-05	0.000122	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MTHFR—autistic disorder	9.61e-06	0.000117	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTEN—autistic disorder	9.53e-06	0.000116	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAPK1—autistic disorder	9.17e-06	0.000111	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOE—autistic disorder	8.95e-06	0.000109	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HRAS—autistic disorder	8.39e-06	0.000102	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PIK3CG—autistic disorder	8.07e-06	9.81e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—autistic disorder	8.03e-06	9.76e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAPK1—autistic disorder	7.75e-06	9.42e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—autistic disorder	7.69e-06	9.34e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HRAS—autistic disorder	7.36e-06	8.94e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—autistic disorder	7.04e-06	8.56e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HRAS—autistic disorder	6.22e-06	7.56e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—autistic disorder	6.13e-06	7.45e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—autistic disorder	5.95e-06	7.23e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTEN—autistic disorder	5.35e-06	6.5e-05	CbGpPWpGaD
